RESUMO
We describe a delayed diagnosis of Di George syndrome, in a 51 yr-old woman, with past medical history of epilepsy, mental retardation, chronic psychosis, nephrocalcinosis. She presented facial dysmorphism, multiple encephalic calcifications, hypocalcemia and lymphopenia. A microdeletion of 22q 11.2 was detected by fluorescence in situ hybridization (FISH), confirming the clinical suspicion .
Assuntos
Diagnóstico Tardio , Síndrome de DiGeorge/diagnóstico , Anormalidades Múltiplas/etiologia , Encefalopatias Metabólicas/diagnóstico por imagem , Encefalopatias Metabólicas/etiologia , Calcinose/diagnóstico por imagem , Calcinose/etiologia , Deleção Cromossômica , Cromossomos Humanos Par 22/ultraestrutura , Síndrome de DiGeorge/genética , Síndrome de DiGeorge/metabolismo , Síndrome de DiGeorge/psicologia , Epilepsia/etiologia , Feminino , Heterozigoto , Humanos , Hipocalcemia/tratamento farmacológico , Hipocalcemia/etiologia , Hipoparatireoidismo/etiologia , Deficiência Intelectual/etiologia , Pessoa de Meia-Idade , Transtornos Psicóticos/etiologia , RadiografiaRESUMO
We report the case of a 67-year-old man, with a past medical history of radiotherapy for nasopharyngeal carcinoma, who presented with the classical features of a hyperthyroidism (H), due to Graves' disease, with a high TSH receptor antibodies (TRAb) titre. Thyrostatic therapy was started, with gradual improvement of the symptoms and of the thyroid function tests. Two years later, TRAb became negative and the therapy was stopped. In the following months a previously unknown anterior pituitary insufficiency became evident. Therapy with cortisone acetate, L-thyroxine and testosterone was started, resulting in prolonged normalization of the clinical picture. Six years later a short relapse of H was observed, simultaneously to a new increase of TRAb titre, requiring the transitory interruption of the L-thyroxine therapy. In a few months span H disappeared and central hypothyroidism manifested again, so that the patient is still taking replacement therapy. This case illustrates how H and hypopituitarism are not mutually exclusive diagnoses and how, even if rarely, central hypothyroidism and H could alternate in the clinical history of the same patient.
Assuntos
Hipertireoidismo/diagnóstico , Hipopituitarismo/diagnóstico , Imunoglobulinas Estimuladoras da Glândula Tireoide/imunologia , Idoso , Cortisona/administração & dosagem , Doença de Graves/diagnóstico , Humanos , Masculino , Testosterona/administração & dosagem , Tiroxina/administração & dosagemRESUMO
Metastases to the pituitary gland are uncommon causes of hypopituitarism, to be particularly considered in patients affected with disseminated cancers, arising in the breast or in the lung. Differential diagnosis could be correctly addressed by the concomitant presence of diabetes insipidus, due to the prominent involvement of the posterior lobe, and by some neuroradiological findings. We report the case of a 58-year-old woman, suffering from advanced breast cancer, who developed diabetes insipidus and anterior hypopituitarism. Magnetic resonance images showed diffuse encephalic metastatic lesions, with a thickened pituitary stalk, loss of high signal intensity of posterior lobe and a mildly enlarged and inhomogeneously enhanced adenohypophysis. Substitutive hormonal therapy was started, but the patient died five months later due to the progression of the neoplastic disease.
Assuntos
Neoplasias da Mama , Carcinoma Ductal de Mama , Hipopituitarismo/etiologia , Neoplasias Hipofisárias/secundário , Neoplasias Ósseas/secundário , Diabetes Insípido Neurogênico/diagnóstico , Diabetes Insípido Neurogênico/etiologia , Diagnóstico Diferencial , Progressão da Doença , Feminino , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Neoplasias Hipofisárias/complicações , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/mortalidade , Fatores de TempoRESUMO
We describe a case of greater saphenous vein thrombosis in a 50-year-old previously healthy man, occurred only 3 weeks after starting testosterone (T) replacement therapy (20 mg/day, gel) for hypergonadotropic hypogonadism. There were no clinical known risk factors for thrombosis. Laboratory assessment of thrombophilia, performed later, revealed only methylenetetrahydrofolate reductase (MTHFR) A1298C polymorphism. On the basis of other recently reported cases, we suppose a relationship between androgenic therapy and venous thrombosis. We suggest the same caution before starting T replacement therapy in male as in female administration of estrogens.
Assuntos
Terapia de Reposição Hormonal/efeitos adversos , Testosterona/efeitos adversos , Trombose Venosa/etiologia , Terapia de Reposição Hormonal/métodos , Humanos , Hipogonadismo/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Veia Safena/patologia , Testosterona/administração & dosagem , Trombose Venosa/patologiaRESUMO
Leydig cell tumors (LTC) are uncommon neoplasms arising from gonadal stroma that account for 1-3% of all testicular tumors. We report a case of LCT in a 36 years old man who had been suffering from painful bilateral gynecomastia for one year. Endocrine function tests showed decreased gonadotropin concentrations, and reduction of testosterone/estradiol ratio. Ultrasonography revealed a 10-12 mm hypoechoic area in the right testis, not evident on physical examination. Right orchiectomy was performed and histological examination confirmed the supposed existence of a LCT. After surgery, the gynecomastia has completely disappeared and hormonal alterations returned to normal.
Assuntos
Ginecomastia/etiologia , Tumor de Células de Leydig/complicações , Tumor de Células de Leydig/diagnóstico , Orquiectomia , Neoplasias Testiculares/complicações , Neoplasias Testiculares/diagnóstico , Adulto , Estradiol/sangue , Humanos , Tumor de Células de Leydig/sangue , Tumor de Células de Leydig/cirurgia , Masculino , Neoplasias Testiculares/sangue , Neoplasias Testiculares/cirurgia , Testosterona/sangue , Resultado do TratamentoRESUMO
We describe the case of an aged patient, presenting an acute onset of flaccid paralysis of the limbs and bulbar weakness, complicated by ab ingestis pneumonia. These neurological findings were the first signs of a thyrotoxic crisis and showed a progressive regression together with the healing of the hyperthyroidism obtained, within two months, utilizing thyroid inhibitors. At the onset, a marked hypokalaemia was present, making possible the hypothesis of a thyrotoxic periodic paralysis. The hypokalaemia was corrected after many infusions of KCl i.v., without obtaining significant modifications of the neurological picture. Taking into consideration the evolution and the results of the instrumental procedures (EMG, MRI) we believe this a rare case of thyrotoxic acute myopathy, with bulbar involvement, casually associated to hypokalaemia.
Assuntos
Paralisia Bulbar Progressiva/etiologia , Quadriplegia/etiologia , Tireotoxicose/complicações , Idoso , Idoso de 80 Anos ou mais , Antitireóideos/uso terapêutico , Paralisia Bulbar Progressiva/diagnóstico , Eletromiografia , Feminino , Humanos , Hipopotassemia/complicações , Imageamento por Ressonância Magnética , Quadriplegia/diagnóstico , Crise Tireóidea/complicações , Crise Tireóidea/diagnóstico , Crise Tireóidea/tratamento farmacológico , Tireotoxicose/tratamento farmacológicoRESUMO
In this case-report we describe two patients with hypothyroidism and increased carcinoembryonic antigen (CEA) serum concentration. The former patient was a woman affected by primary autoimmune hypothyroidism, the latter by secondary hypothyroidism in empty sella syndrome. In both of the patients we found no evidence of neoplastic disease and CEA serum concentrations reverted almost completely to the normal range values after the patients were given the hormonal replacement therapy with L-thyroxine. Although the association of hypothyroidism with elevated CEA serum concentrations has been already reported in the literature, hypothyroidism is usually disregarded when a physician is facing with a patient with increased CEA levels. On the contrary, our data suggest that hypothyroidism should be taken into account in the diagnostic work-up of these patients, such as smoking, cholestasis, impaired liver function, chronic inflammatory bronchial and bowel disease.